Oasmia Pharmaceutical AB | Cash Flow
Fiscal year is May-April. All values SEK Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
98,091.00
108,225.00
132,691.00
140,481.00
103,724.00
120,132
Depreciation, Depletion & Amortization
4,941.00
5,190.00
4,804.00
4,508.00
5,350.00
-
Other Funds
421.00
536.00
878.00
8,379.00
8,955.00
10,636
Funds from Operations
93,571.00
103,571.00
128,765.00
127,594.00
107,329.00
109,495
Changes in Working Capital
6,672.00
4,095.00
640.00
5,417.00
16,305.00
9,344
Net Operating Cash Flow
86,899.00
107,666.00
128,125.00
133,011.00
123,634.00
118,839
Capital Expenditures
35,682.00
21,027.00
19,934.00
7,960.00
21,452.00
Sale of Fixed Assets & Businesses
-
72.00
-
-
-
Purchase/Sale of Investments
-
50,000.00
30,000.00
19,999.00
-
Net Investing Cash Flow
35,682.00
69,755.00
10,066.00
12,039.00
21,452.00
Issuance/Reduction of Debt, Net
40,000.00
20,000.00
28,000.00
62,000.00
15,000.00
Net Financing Cash Flow
107,865.00
156,017.00
117,449.00
122,755.00
132,656.00
Net Change in Cash
14,716.00
21,404.00
629.00
1,793.00
12,420.00
Free Cash Flow
89,037.00
111,287.00
130,099.00
133,526.00
124,049.00
Other Sources
-
1,200.00
-
-
-
Change in Capital Stock
67,865.00
176,017.00
89,449.00
60,755.00
147,656.00
Exchange Rate Effect
-
-
19.00
10.00
10.00
About Oasmia Pharmaceutical AB
View Profile
